Thorne HealthTech (THRN) Stock Forecast, Price Target & Predictions
THRN Stock Forecast
Thorne HealthTech stock forecast is as follows: an average price target of $5.75 (represents a -43.57% downside from THRN’s last price of $10.19) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
THRN Price Target
The average price target for Thorne HealthTech (THRN) is $5.75 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $5.50. This represents a potential -43.57% downside from THRN's last price of $10.19.
THRN Analyst Ratings
According to 1 Wall Street analysts, Thorne HealthTech's rating consensus is 'Buy'. The analyst rating breakdown for THRN stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Thorne HealthTech Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 17, 2022 | - | Canaccord Genuity | $5.50 | $4.15 | 32.53% | -46.03% |
| Nov 11, 2022 | - | RBC Capital | $6.00 | $4.08 | 47.06% | -41.12% |
The latest Thorne HealthTech stock forecast, released on Nov 17, 2022 by Canaccord Genuity company, set a price target of $5.50, which represents a 32.53% increase from the stock price at the time of the forecast ($4.15), and a -46.03% decrease from THRN last price ($10.19).
Thorne HealthTech Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $10.19 | $10.19 | $10.19 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Thorne HealthTech stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Thorne HealthTech's last price of $10.19. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 17, 2022 | Canaccord Genuity | - | Buy | Initialise |
Thorne HealthTech's last stock rating was published by Canaccord Genuity on Nov 17, 2022. The company Initialise its THRN rating from "null" to "Buy".
Thorne HealthTech Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| NOMD | Nomad Foods | $16.25 | $24.00 | 47.69% | Buy |
| CENT | Central Garden & Pet Company | $36.80 | $50.67 | 37.69% | - |
| POST | Post | $109.47 | $135.00 | 23.32% | Buy |
| LANC | Lancaster Colony | $187.88 | $216.00 | 14.97% | Buy |
| NATR | Nature's Sunshine Products | $15.96 | $18.00 | 12.78% | - |
| SMPL | Simply Good Foods Company | $36.47 | $40.50 | 11.05% | Buy |
| BRBR | BellRing Brands | $72.14 | $44.00 | -39.01% | Buy |
| THRN | Thorne HealthTech | $10.19 | $5.75 | -43.57% | Buy |